Zacho, Helle D; Ravn, Søren; Afshar-Oromieh, Ali; Fledelius, Joan; Ejlersen, June A; Petersen, Lars J (2020). Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy. EJNMMI research, 10(1), p. 31. Springer 10.1186/s13550-020-00618-0
|
Text
13550_2020_Article_618.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
PURPOSE
To investigate the added value and diagnostic accuracy of 68Ga-PSMA PET/CT versus bone scintigraphy (BS) for bone metastasis detection at the primary staging of prostate cancer (PCa).
METHODS
Inclusion criteria involved consecutive patients with newly diagnosed intermediate- to high-risk PCa, who had undergone BS, mostly with supplementary SPECT/low-dose CT, and 68Ga-PSMA-11 PET/CT within less than 3 months without therapy initiation between the two investigations. BS was evaluated according to clinical routine and reported as no bone metastases (M0), bone metastases (M1), or equivocal (Me). The 68Ga-PSMA-11 PET/CT was blindly evaluated by three specialists as M0, M1, or Me at the patient level. Sensitivity analyses were conducted using a "best valuable comparator" using all available imaging and clinical follow-up as a reference.
RESULTS
In total, 112 patients were included; 68Ga-PSMA-11 PET/CT showed a sensitivity of 1.00, specificity of 0.93-0.96, positive predictive value of 0.74-0.81, and negative predictive value of 1.00. 68Ga-PSMA-11 PET/CT revealed bone metastases in 8 of 81 patients with M0 disease according to BS. 68Ga-PSMA-11 PET/CT confirmed the presence of bone metastases in all patients (n = 9) with M1 disease according to BS. In patients with Me by BS, 68Ga-PSMA PET/CT provided a definite result in 20 of 22 patients. 68Ga-PSMA-11 PET/CT resulted in a false-positive answer in four patients with solitary rib lesions.
CONCLUSION
68Ga-PSMA-11 PET/CT revealed bone metastases in 10% of patients without bone metastases on BS and in 36% patients with indeterminate BS. However, solitary PSMA-avid lesions in the ribs should be interpreted cautiously as they may represent false-positive findings.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Afshar Oromieh, Ali |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2191-219X |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Sabine Lanz |
Date Deposited: |
04 Jan 2021 09:18 |
Last Modified: |
05 Dec 2022 15:42 |
Publisher DOI: |
10.1186/s13550-020-00618-0 |
PubMed ID: |
32270300 |
Uncontrolled Keywords: |
Bone metastases Bone scan Bone scintigraphy Newly diagnosed prostate cancer PSMA PET/CT |
BORIS DOI: |
10.48350/149401 |
URI: |
https://boris.unibe.ch/id/eprint/149401 |
Actions (login required)
 |
Edit item |